These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 18544959

  • 1. Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
    Ferrandina G, Macchia G, Legge F, Deodato F, Forni F, Digesù C, Carone V, Morganti AG, Scambia G.
    Oncology; 2008; 74(1-2):42-9. PubMed ID: 18544959
    [Abstract] [Full Text] [Related]

  • 2. Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
    Ferrandina G, Distefano M, Smaniotto D, Morganti A, Paglia A, Macchia G, Corvari B, Lorusso D, Scambia G.
    Gynecol Oncol; 2006 Nov; 103(2):500-5. PubMed ID: 16677692
    [Abstract] [Full Text] [Related]

  • 3. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
    Sugiyama T, Nishida T, Hasuo Y, Fujiyoshi K, Yakushiji M.
    Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820
    [Abstract] [Full Text] [Related]

  • 4. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
    Jurado M, Martínez-Monge R, García-Foncillas J, Azinovic I, Aristu J, López-García G, Brugarolas A.
    Gynecol Oncol; 1999 Jul; 74(1):30-7. PubMed ID: 10385548
    [Abstract] [Full Text] [Related]

  • 5. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N, van der Velden J, Ten Hoor KA, Boezen HM, de Vries EG, Schilthuis MS, Mourits MJ, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AG.
    J Clin Oncol; 2005 Mar 01; 23(7):1455-62. PubMed ID: 15735121
    [Abstract] [Full Text] [Related]

  • 6. Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility.
    Distefano M, Ferrandina G, Smaniotto D, Margariti AP, Zannoni G, Macchia G, Manfredi R, Mangiacotti MG, Cellini N, Scambia G.
    Oncology; 2004 Mar 01; 67(2):103-11. PubMed ID: 15539913
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
    Lee YY, Choi CH, Sung CO, Do IG, Huh S, Song T, Kim MK, Kim HJ, Kim TJ, Lee JW, Kim BG, Bae DS.
    Gynecol Oncol; 2012 Jan 01; 124(1):92-7. PubMed ID: 22014631
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures.
    Ferrandina G, Legge F, Fagotti A, Fanfani F, Distefano M, Morganti A, Cellini N, Scambia G.
    Gynecol Oncol; 2007 Oct 01; 107(1 Suppl 1):S127-32. PubMed ID: 17727936
    [Abstract] [Full Text] [Related]

  • 10. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D, Wu M, Ren T, Wan XR, Feng FZ, Huang HF, Yang JX, Shen K, Xiang Y.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug 01; 47(8):577-81. PubMed ID: 23141176
    [Abstract] [Full Text] [Related]

  • 11. Expression of class III beta tubulin in cervical cancer patients administered preoperative radiochemotherapy: correlation with response to treatment and clinical outcome.
    Ferrandina G, Martinelli E, Zannoni GF, Distefano M, Paglia A, Ferlini C, Scambia G.
    Gynecol Oncol; 2007 Feb 01; 104(2):326-30. PubMed ID: 17030352
    [Abstract] [Full Text] [Related]

  • 12. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
    Hsu FM, Lin CC, Lee JM, Chang YL, Hsu CH, Tsai YC, Lee YC, Cheng JC.
    J Surg Oncol; 2008 Jul 01; 98(1):34-41. PubMed ID: 18449912
    [Abstract] [Full Text] [Related]

  • 13. Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy.
    Ferrandina G, Distefano M, Ludovisi M, Morganti A, Smaniotto D, D'Agostino G, Fanfani F, Scambia G.
    Ann Surg Oncol; 2007 Mar 01; 14(3):1129-35. PubMed ID: 17206484
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
    Kim YB, Kim GE, Cho NH, Pyo HR, Shim SJ, Chang SK, Park HC, Suh CO, Park TK, Kim BS.
    Cancer; 2002 Aug 01; 95(3):531-9. PubMed ID: 12209745
    [Abstract] [Full Text] [Related]

  • 15. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
    Micke O, Bruns F, Schäfer U, Prott FJ, Willich N.
    Anticancer Res; 2005 Aug 01; 25(3A):1663-6. PubMed ID: 16033078
    [Abstract] [Full Text] [Related]

  • 16. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone.
    Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, Lee SP, Lee CC, Tang SG, Hsueh S.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):492-9. PubMed ID: 15925454
    [Abstract] [Full Text] [Related]

  • 17. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
    Zhang R, Li B, Bai P, Li HJ, Li SM, Wu LY, Li W.
    Zhonghua Zhong Liu Za Zhi; 2011 Aug 01; 33(8):616-20. PubMed ID: 22325224
    [Abstract] [Full Text] [Related]

  • 18. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
    Xiong Y, Liang LZ, Zheng M, Wei M, Shen Y.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan 01; 42(1):29-33. PubMed ID: 17331418
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, Huang YJ, Wang CY, Lu HM, Tsai CC, Ma YY, Fu HC, Wang YM, Wang CJ.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):1105-13. PubMed ID: 20932670
    [Abstract] [Full Text] [Related]

  • 20. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kim YB, Kim GE, Pyo HR, Cho NH, Keum KC, Lee CG, Seong J, Suh CO, Park TK.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):822-9. PubMed ID: 15465199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.